APNHF
Price
$7.25
Change
-$4.99 (-40.77%)
Updated
Jun 6 closing price
Capitalization
2.65B
INNPF
Price
$0.15
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
36.56M
Interact to see
Advertisement

APNHF vs INNPF

Header iconAPNHF vs INNPF Comparison
Open Charts APNHF vs INNPFBanner chart's image
Aspen Pharmacare Holdings
Price$7.25
Change-$4.99 (-40.77%)
Volume$407
Capitalization2.65B
Innocan Pharma
Price$0.15
Change-$0.00 (-0.00%)
Volume$7.44K
Capitalization36.56M
APNHF vs INNPF Comparison Chart in %
Loading...
APNHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APNHF vs. INNPF commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHF is a Hold and INNPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (APNHF: $7.25 vs. INNPF: $20.05)
Brand notoriety: APNHF and INNPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: APNHF: 100% vs. INNPF: 170%
Market capitalization -- APNHF: $2.65B vs. INNPF: $36.56M
APNHF [@Pharmaceuticals: Generic] is valued at $2.65B. INNPF’s [@Pharmaceuticals: Generic] market capitalization is $36.56M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.78B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHF’s FA Score shows that 1 FA rating(s) are green whileINNPF’s FA Score has 1 green FA rating(s).

  • APNHF’s FA Score: 1 green, 4 red.
  • INNPF’s FA Score: 1 green, 4 red.
According to our system of comparison, INNPF is a better buy in the long-term than APNHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APNHF’s TA Score shows that 2 TA indicator(s) are bullish while INNPF’s TA Score has 7 bullish TA indicator(s).

  • APNHF’s TA Score: 2 bullish, 0 bearish.
  • INNPF’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, INNPF is a better buy in the short-term than APNHF.

Price Growth

APNHF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while INNPF (@Pharmaceuticals: Generic) price change was +5.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.87%. For the same industry, the average monthly price growth was +11.08%, and the average quarterly price growth was +76.49%.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.87% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APNHF($2.65B) has a higher market cap than INNPF($36.6M). INNPF YTD gains are higher at: 6.759 vs. APNHF (-40.792). APNHF has higher annual earnings (EBITDA): 8.02B vs. INNPF (219M). APNHF has more cash in the bank: 6.8B vs. INNPF (5.01M). INNPF has less debt than APNHF: INNPF (1.44B) vs APNHF (35.5B). APNHF has higher revenues than INNPF: APNHF (45.5B) vs INNPF (727M).
APNHFINNPFAPNHF / INNPF
Capitalization2.65B36.6M7,232%
EBITDA8.02B219M3,663%
Gain YTD-40.7926.759-604%
P/E Ratio12.56N/A-
Revenue45.5B727M6,259%
Total Cash6.8B5.01M135,863%
Total Debt35.5B1.44B2,462%
FUNDAMENTALS RATINGS
APNHF: Fundamental Ratings
APNHF
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
31

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APNHFINNPF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
56%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
20%
Bullish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
21%
Bullish Trend 2 days ago
43%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
48%
Declines
ODDS (%)
N/A
Bearish Trend 21 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
APNHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TADCX25.61N/A
N/A
Transamerica US Growth C
GLNJX22.10N/A
N/A
MFS Global New Discovery R1
COSOX12.96N/A
N/A
Columbia Overseas Core Institutional 3
SUSIX13.49-0.05
-0.37%
State Street Instl US Equity Inv
JDMAX140.85-1.23
-0.87%
Janus Henderson Enterprise A

APNHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, APNHF has been loosely correlated with GEDSF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if APNHF jumps, then GEDSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHF
1D Price
Change %
APNHF100%
N/A
GEDSF - APNHF
51%
Loosely correlated
N/A
MSTH - APNHF
39%
Loosely correlated
N/A
ORXOY - APNHF
29%
Poorly correlated
N/A
INNPF - APNHF
20%
Poorly correlated
-0.55%
QNTM - APNHF
4%
Poorly correlated
-2.10%
More

INNPF and

Correlation & Price change

A.I.dvisor tells us that INNPF and HYEX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNPF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNPF
1D Price
Change %
INNPF100%
-0.55%
HYEX - INNPF
20%
Poorly correlated
+10.67%
APNHF - INNPF
20%
Poorly correlated
N/A
BIOVF - INNPF
20%
Poorly correlated
N/A
KKPCF - INNPF
6%
Poorly correlated
N/A
VEXTF - INNPF
6%
Poorly correlated
-2.57%
More